Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

Organon

Status and phase: Completed; Phase 3

Conditions: Hypercholesterolemia

Treatments: Drug: MK0653, ezetimibe; Drug: Comparator: statins

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092586

2004_037

0653-040

Details and patient eligibility

About

The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol.

Full description

The duration of treatment is 6 weeks.

Enrollment: 2,904 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• High cholesterol levels that are identified by specific laboratory values

Exclusion criteria

• Active liver disease
• Any condition or situation which would interfere with participation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind